The COVID-19 Serology Studies Workshop: Recommendations and Challenges.
Journal
Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918
Informations de publication
Date de publication:
14 07 2020
14 07 2020
Historique:
received:
26
05
2020
revised:
11
06
2020
accepted:
16
06
2020
pubmed:
2
7
2020
medline:
24
7
2020
entrez:
2
7
2020
Statut:
ppublish
Résumé
The development, validation, and appropriate application of serological assays to detect antibodies to SARS-CoV-2 are essential to determining seroprevalence of this virus in the United States and globally and in guiding government leadership and the private sector on back-to-work policies. An interagency working group of the US Department of Health and Human Services convened a virtual workshop to identify knowledge gaps and key outstanding scientific issues and to develop strategies to fill them. Key outcomes of the workshop included recommendations for (1) advancing serology assays as a tool to better understand SARS-CoV-2 infection and (2) conducting crucial serology field studies to advance an understanding of immunity to SARS-CoV-2, leading to protection and duration of protection, including the correlation between serological test results and risk of reinfection.
Identifiants
pubmed: 32610080
pii: S1074-7613(20)30267-3
doi: 10.1016/j.immuni.2020.06.012
pmc: PMC7309808
pii:
doi:
Substances chimiques
Antibodies, Viral
0
Types de publication
Clinical Conference
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-5Informations de copyright
Copyright © 2020.
Références
Nat Med. 2020 Jul;26(7):1033-1036
pubmed: 32398876
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32381641
Curr Protoc Microbiol. 2020 Jun;57(1):e100
pubmed: 32302069
Nat Med. 2013 Oct;19(10):1305-12
pubmed: 24056771
Nat Commun. 2020 Sep 17;11(1):4704
pubmed: 32943637
Lancet Microbe. 2020 Nov;1(7):e283-e289
pubmed: 33015652